Since 1958, The Beasley Firm has fought for injured patients and consumers, recovering over $2 billion for our clients through hundreds of multi-million dollar settlements and jury verdicts. If you or a loved one developed bladder cancer after taking Actos, contact our dangerous and recalled drug lawyers for a confidential, no-obligation consultation by filling out our online contact form or by calling The Beasley Firm’s main line at 1-(888) 823-5291. You can also directly call the office of The Beasley Firm attorney heading the firm’s Actos bladder cancer lawsuits, Max Kennerly, at (215) 931-2634.
Actos (pioglitazone) was previously the best-selling Type 2 Diabetes drug in the world, but recent studies have shown that patients on Actos have a far higher rate of bladder cancer than patients on other diabetes medications. Nearly 1,000 Actos bladder cancer lawsuits have been filed. Most of the cases have either been filed in the federal courts nationwide or in state court in Illinois, where Takeda Pharmaceuticals is based. The cases are moving swiftly, but consolidated mass torts litigation isn’t like a class action — you have to file your own individual claim if you want to preserve your right to compensation.
Who Can File An Actos Lawsuit?
There are a variety of claims all Actos patients could in theory raise, even if they did not develop a disease, including claims for consumer fraud, misrepresentation, and negligence. Our law firm focuses on serious injury and wrongful death cases, and so we have limited our Actos litigation practice to patients diagnosed with bladder cancer after taking Actos at least three months. We accept cases where patients were former smokers.
Actos is sometimes sold in combination with metformin (Actoplus Met, Actoplus Met XR) and or in combination with glimepiride (Duetact). If you developed bladder, kidney, pancreatic or liver cancers or tumors after taking any of those medications, you should consult with an Actos attorney.
Is There An Actos Class Action?
We don’t file our Actos lawsuits as a class action. Each client’s case is filed as an individual case, with individual representation. At the moment, there are no certified Actos class actions. Due to recent court rulings over the past few years in other pharmaceutical negligence cases, it is unlikely that there will be any class actions.
There is, however, a federal “multi-district litigation” panel, so that all Actos lawsuits in the federal courts are consolidated for pre-trial proceedings in the Western District of Louisiana. Most state courts with a significant number of Actos lawsuits, including Illinois, Missouri, and California, where Takeda subsidies are based, have also consolidated lawsuits filed within their state courts.
Has The FDA Recalled Actos Or Taken It Off The Market?
The FDA has not recalled Actos or ordered that it be pulled from the market, but it has issued several new warnings about the drug.
On September 17, 2010, the FDA issued a Drug Safety Communication noting that, five years into a ten-year study of any association between Actos and bladder cancer, a link had been found for patients who took Actos for more than 24 months, with a higher dose correlated with a higher risk of bladder cancer.
On June 15, 2011, the FDA issued an updated warning that even just one year of pioglitazone use raises the risk of bladder cancer by more than 40%, or an extra 28 cases a year for every 100,000 people taking it. The FDA also recommended doctors not prescribe Actos for patients who have or have had bladder cancer.
On August 4, 2011, the FDA published new warning labels for Actos, which recommends doctors should not prescribe pioglitazone to patients with active bladder cancer, and exercise caution prescribing pioglitazone to patients with a prior history of bladder cancer. The drug labels recommend that patients should report to their doctor if they “experience any sign of blood in the urine or a red color in the urine or other symptoms such as new or worsening urinary urgency or pain on urination since starting pioglitazone, as these may be due to bladder cancer.”
The National Library of Medicine’s PubMed Health page on Pioglitzaone, which follows the FDA-approved information, was last updated October 15, 2011. It does not include a ‘black box’ warning for bladder cancer. Instead, it reports only, “In clinical studies, more people who took pioglitazone for more than one year developed bladder cancer than people who did not take pioglitazone.”
We and other consumer groups have been pushing the FDA to mandate a stronger warning on Actos, given scientific data — including this study in France — showing an increase in bladder cancer among men even when those men took Actos for less than one year. We do not believe there is any doubt that Actos increases the likelihood of bladder cancer in both men and women, and we believe current and future Actos patients should be warned of that important fact.
Who Is Behind Those Actos Commercials On TV?
Hundreds of law firms have begun advertising heavily for Actos claims during daytime and late-night programming. If you call those numbers on television, you’ll usually get routed to a call center that will take down your information and then pass it along to another law firm entirely. Sometimes those other law firms are experienced and motivated trial lawyers, sometimes not.
We recommend you take some time investigating the attorneys and their law firms before you sign up with them. You don’t have to hire a firm that is close to you — the Actos litigation is handed nationwide — but you should hire a firm with a history of representing clients at trial, not just in settlement negotiations. We’ve been representing serious injury and wrongful death clients at trial for over fifty years. When we tell insurance and pharmaceutical companies that we’ll see them in court, we mean it.
If you developed bladder cancer after taking Actos, contact our dangerous drug lawyers for a free and confidential consultation by filling out this online form or by calling The Beasley Firm at 1-(888) 823-5291. We are based in Philadelphia, with attorneys licensed in Pennsylvania, New Jersey and Delaware, and we represent Actos clients nationwide.
Read more about Actos and bladder cancer attorneys and lawsuits, including our blog posts:
- Ongoing Safety Review Data for Actos (pioglitazone) Reveals Possibility of Bladder Cancer
- Actos Can Also Cause Diabetic Macular Edema (DME) and Blindness, in Addition to Bladder Cancer
- Illinois and California Actos Bladder Cancer Lawsuits to Remain in State Courts
- Actos Users In Kentucky, Louisiana, and Tennessee Who Developed Bladder Cancer Should File Claims Soon